Alivus Life Sciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 08, 2025. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences Limited held its Annual General Meeting on September 8, 2025. The company has submitted the voting results along with the Scrutinizer's report to the stock exchange. This is a standard regulatory compliance filing following the conclusion of the AGM. Investors should review the voting results to understand how shareholders voted on key resolutions such as financial statements, director appointments, and any special business.
Routine post-AGM compliance filing with no immediate impact on share price. Investors should review the voting pattern for any signals on shareholder dissent on key resolutions.